Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Results- Unaudited Financial Results For The Quarter Ended June 30, 2022

Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform that the Board of Directors of the Company at its Meeting held today i.e. Thursday, August 11, 2022, inter alia, considered and approved the Unaudited Financial Results along with the Limited Review Report for the quarter ended June 30, 2022, which has been duly reviewed and recommended by the Audit Committee. In this regard, we are enclosing herewith the following: 1. Un-Audited Financial Results for the Quarter ended June 30, 2022. 2. Limited Review Report received from the Statutory Auditor of the Company on the Un-Audited Financial Results for the Quarter ended June 30, 2022. 3. Investor Presentation on the financial results. The meeting of the Board of Directors commenced at 6:00 p.m. and concluded at 9:00 p.m.
11-08-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of Newspaper published today in Business Standard (All Editions in English language) and Mumbai Lakshadeep (Mumbai Edition in Marathi language) which includes the following information: 1. Intimation of 38th Annual General Meeting (AGM) of our Company to be held on Friday, September 02, 2022 at 3.30 p.m. (IST) through video conferencing (VC) / other audio-visual means (OAVM). 2. Completion of email dissemination on Wednesday, August 10, 2022 of the Notice of 38th AGM and the Annual Report for FY 2021-22 to the members whose email IDs are registered with the Company/ Depositories. 3. Details of remote e-voting facility provided to the shareholders of the Company, to enable them to cast their votes on the resolutions proposed to be passed at the AGM. Kindly take the same on record.
11-08-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Reg. 34 (1) Annual Report.

We hereby inform that the 38th Annual General Meeting (''AGM'') of the Company is scheduled to be held on Friday, September 2, 2022 at 3.30 P.M. (IST) through Video Conference / Other Audio Visual Means ('VC/OAVM'). Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the Financial Year 2021-22 along with Notice of the AGM. The Annual Report and the Notice of AGM are being sent to the members through electronic mode and the same are also uploaded on the Company''s website at www.gufic.com. Kindly take the same on your record.
10-08-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Intimation Of Record Date For Final Dividend & 38Th Annual General Meeting

Pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the record date for the purpose of AGM and for payment of final dividend for the financial year ended March 31, 2022 is Thursday, August 25, 2022 and other details in this regard is attached herewith.
10-08-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Shareholders Meeting - 38Th Annual General Meeting Of The Company Scheduled To Be Held On Friday, September 2, 2022

With reference to the above captioned subject, we wish to inform you that the 38th Annual General Meeting ("AGM") of the Company will be held on Friday, September 2, 2022 at 3:30 p.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM) to transact the Ordinary and Special Business as set out in the Notice convening the 38th AGM dated July 14, 2022. A copy of the Notice of 38th AGM is enclosed herewith.
10-08-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copies of Newspaper published today in Business Standard (Mumbai Edition in English language) and Mumbai Lakshadeep (Mumbai Edition in Marathi language) in compliance with General Circular No. 20/2020 dated May 5, 2020, intimating that the 38th Annual General Meeting of the Company will be held on Friday, September 2, 2022 at 3.30 p.m. (IST) through Video Conferencing / Other Audio Visual Means ('VC/ OAVM') and providing other details regarding e-Voting, procedure for registering email addresses and updation of bank account details. Kindly take the same on record.
09-08-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company will host an Earnings Conference Call for Investors/Analysts on Friday, August 12, 2022, at 16:30 p.m. (IST), during which officials of the Company will discuss the business background/prospects and financial performance of the Company and take questions. The details of the Earnings Conference call are mentioned in the Call Invite enclosed herewith.
05-08-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2022

GUFIC BIOSCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2022. Further in continuation to our disclosure on Closure of Trading Window dated June 29, 2022 and pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the trading window in respect of dealing in the Equity Shares of the Company for all the Directors and Designated Persons of the Company along with their immediate relatives, shall continue to remain closed until 48 hours after declaration of the Unaudited Financial Results of the Company for the quarter ended June 30, 2022.
04-08-2022
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Board Meeting Outcome for Outcome Of The Board Of Directors Meeting Held On Thursday, July 14, 2022

In compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of Directors of the Company at its meeting held today i.e. Thursday, July 14, 2022, inter alia, considered and approved continuation of Directorship of Mr. Dilip Ghosh (DIN: 00412406) as a Whole Time Director of the Company as per the existing term of five (5) years commencing from November 12, 2020 till November 11, 2025 (inclusive of both days) even after attaining the age of 70 years on December 29, 2022, based on the recommendation of Nomination & Remuneration Committee and subject to approval of shareholders in the ensuing 38th Annual General Meeting by way of special resolution.
14-07-2022
Bigul

Gufic Biosciences to invest 240 crore in new units

An upcoming facility in Indore will cater to domestic and global markets
11-07-2022
Next Page
Close

Let's Open Free Demat Account